Home / Inspections / 1202781

FDA Inspection 1202781 — Reproductive Medicine Associates Of Philadelphia, P.c.

Reproductive Medicine Associates Of Philadelphia, P.c. — FEI 3005191316

The FDA completed an inspection of Reproductive Medicine Associates Of Philadelphia, P.c. on April 5, 2023 in Abington, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 5, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Abington, PA (United States)

Facility

Other inspections at this facility

  • 1294502 (NAI Thu Dec 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1122589 (NAI Wed Mar 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1039894 (NAI Wed Dec 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 896854 (NAI Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 770438 (NAI Fri Mar 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources